| Infant Reflux and Pediatric GERD Info / Feeding and Nutrition Info / Other Conditions / Products / Our Community |
CDC
November 2006
Chiari malformations (CMs) are structural defects in the cerebellum, the part
of the brain that controls balance. Normally the cerebellum and parts of the
brainstem sit in an indented space at the lower rear of the skull, above the
foramen magnum (a funnel-like opening to the spinal canal). When part of the
cerebellum is located below the foramen magnum, it is called a Chiari
malformation.
CMs may develop when the bony space is smaller than normal, causing the
cerebellum and brainstem to be pushed downward into the foramen magnum and into
the upper spinal canal. The resulting pressure on the cerebellum and brainstem
may affect functions controlled by these areas and block the flow of
cerebrospinal fluid (CSF) — the clear liquid that surrounds and cushions the
brain and spinal cord — to and from the brain.
The exact cause of CM is unknown. Many scientists believe that the condition is usually the result of a structural defect that occurs during fetal development. CMs may also be genetic — some research shows the condition may appear in more than one family member. Other possible causes include exposure to harmful substances, lack of proper vitamins or nutrients in the mother’s diet during fetal development, injury, infection, or aging.
CMs are classified by the severity of the disorder and the parts of the brain
that protrude into the spinal canal.
Type I involves the extension of the cerebellar tonsils (the lower part of the
cerebellum) into the foramen magnum, without involving the brainstem. Normally,
only the spinal cord passes through this opening. Type I — which may not cause
symptoms — is the most common form of CM and is usually first noticed in
adolescence or adulthood, often by accident during an examination for another
condition.
Type II, also called classic CM, involves the extension of both cerebellar and
brainstem tissue into the foramen magnum. Also, the cerebellar vermis (the nerve
tissue that connects the two halves of the cerebellum) may be only partially
complete or absent. Type II is usually accompanied by a myelomeningocele — a
form of spina bifida that occurs when the spinal canal and backbone do not close
before birth, causing the spinal cord and its protective membrane to protrude
through a sac-like opening in the back. A myelomeningocele usually results in
partial or complete paralysis of the area below the spinal opening. The term
Arnold-Chiari malformation (named after two pioneering researchers) is specific
to Type II malformations.
Type III is the most serious form of CM. The cerebellum and brainstem protrude,
or herniate, through the foramen magnum and into the spinal cord. Part of the
brain’s fourth ventricle, a cavity that connects the upper parts of the brain
and circulates CSF, may also protrude through the hole and into the spinal cord.
In rare instances, the herniated cerebellar tissue can cause an occipital
encephalocele, a pouch-like structure that protrudes out of the back of the head
or the neck and contains brain matter. The covering of the brain or spinal cord
can also protrude through an abnormal opening in the back or skull. Type III
causes severe neurological defects.
Type IV involves an incomplete or underdeveloped cerebellum — a condition known
as cerebellar hypoplasia. In this rare form of CM, the cerebellar tonsils are
located further down the spinal canal, parts of the cerebellum are missing, and
portions of the skull and spinal cord may be visible.
Another form of the disorder, under debate by some scientists, is Type 0, in
which there is no protrusion of the cerebellum through the foramen magnum but
headache and other symptoms of CM are present.
Many persons with a Type I CM do not have symptoms and may not know they have the condition. Patients with other CM types may complain of neck pain, balance problems, muscle weakness, numbness or other abnormal feelings in the arms or legs, dizziness, vision problems, difficulty swallowing, ringing or buzzing in the ears, hearing loss, vomiting, insomnia, depression, or headache made worse by coughing or straining. Hand coordination and fine motor skills may be affected. Symptoms may change for some patients, depending on the buildup of CSF and resulting pressure on the tissues and nerves. Adolescents and adults who have CM but no symptoms initially may, later in life, develop signs of the disorder. Infants may have symptoms from any type of CM and may have difficulty swallowing, irritability when being fed, excessive drooling, a weak cry, gagging or vomiting, arm weakness, a stiff neck, breathing problems, developmental delays, and an inability to gain weight.
Individuals who have a CM often have these related conditions:
Hydrocephalus is an excessive buildup of CSF in the brain. A CM can block the
normal flow of this fluid, resulting in pressure within the head that can cause
mental defects and/or an enlarged or misshapen skull. Severe hydrocephalus, if
left untreated, can be fatal. The disorder can occur with any type of CM, but is
most commonly associated with Type II.
Spina bifida is the incomplete development of the spinal cord and/or its
protective covering. The bones around the spinal cord don’t form properly,
leaving part of the cord exposed and resulting in partial or complete paralysis.
Patients with Type II CM usually have a myelomeningocele, a form of spina bifida
in which the bones in the back and lower spine don’t form properly and extend
out of the back in a sac-like opening.
Syringomyelia, or hydromyelia, is a disorder in which a CSF-filled tubular cyst,
or syrinx, forms within the spinal cord’s central canal. The growing syrinx
destroys the center of the spinal cord, resulting in pain, weakness, and
stiffness in the back, shoulders, arms, or legs. Other symptoms may include
headaches and a loss of the ability to feel extremes of hot or cold, especially
in the hands. Some individuals also have severe arm and neck pain.
Tethered cord syndrome occurs when the spinal cord attaches itself to the bony
spine. This progressive disorder causes abnormal stretching of the spinal cord
and can result in permanent damage to the muscles and nerves in the lower body
and legs. Children who have a myelomeningocele have an increased risk of
developing a tethered cord later in life.
Spinal curvature is common among patients with syringomyelia or CM Type I. Two
types of spinal curvature can occur in conjunction with CMs: scoliosis, a
bending of the spine to the left or right; and kyphosis, a forward bending of
the spine. Spinal curvature is seen most often in children with CM, whose
skeleton has not fully matured.
CMs may also be associated with certain hereditary syndromes that affect
neurological and skeletal abnormalities, other disorders that affect bone
formation and growth, fusion of segments of the bones in the neck, and extra
folds in the brain.
In the past, it was estimated that the condition occurs in about one in every 1,000 births. However, the increased use of diagnostic imaging has shown that CM may be much more common. Complicating this estimation is the fact that some children who are born with the condition may not show symptoms until adolescence or adulthood, if at all. CMs occur more often in women than in men and Type II malformations are more prevalent in certain groups, including people of Celtic descent.
Many people with CMs have no symptoms and their malformations are discovered
only during the course of diagnosis or treatment for another disorder. The
doctor will perform a physical exam and check the patient’s memory, cognition,
balance (a function controlled by the cerebellum), touch, reflexes, sensation,
and motor skills (functions controlled by the spinal cord). The physician may
also order one of the following diagnostic tests:
An X-ray uses electromagnetic energy to produce images of bones and certain
tissues on film. An X-ray of the head and neck cannot reveal a CM but can
identify bone abnormalities that are often associated with CM. This safe and
painless procedure can be done in a doctor’s office and takes only a few
minutes.
Computed tomography (also called a CTscan) uses X-rays and a computer to produce
two-dimensional pictures of bone and vascular irregularities, certain brain
tumors and cysts, brain damage from head injury, and other disorders. Scanning
takes about 20 minutes (a CT of the brain or head may take slightly longer).
This painless, noninvasive procedure is done at an imaging center or hospital on
an outpatient basis and can identify hydrocephalus and bone abnormalities
associated with CM.
Magnetic resonance imaging (MRI) is the imaging procedure most often used to
diagnose a CM. Like CT, it is painless and noninvasive and is performed at an
imaging center or hospital. MRI uses radio waves and a powerful magnetic field
to produce either a detailed three-dimensional picture or a two-dimensional
“slice” of body structures, including tissues, organs, bones, and nerves.
Depending on the part(s) of the body to be scanned, MRI can take up to an hour
to complete.
Some CMs are asymptomatic and do not interfere with a person’s activities of
daily living. In other cases, medications may ease certain symptoms, such as
pain.
Surgery is the only treatment available to correct functional disturbances or
halt the progression of damage to the central nervous system. Most patients who
have surgery see a reduction in their symptoms and/or prolonged periods of
relative stability. More than one surgery may be needed to treat the condition.
Posterior fossa decompression surgery is performed on adult CM patients to
create more space for the cerebellum and to relieve pressure on the spinal
column. Surgery involves making an incision at the back of the head and removing
a small portion of the bottom of the skull (and sometimes part of the spinal
column) to correct the irregular bony structure. The neurosurgeon may use a
procedure called electrocautery to shrink the cerebellar tonsils. This surgical
technique involves destroying tissue with high-frequency electrical currents.
A related procedure, called a spinal laminectomy, involves the surgical removal
of part of the arched, bony roof of the spinal canal (the lamina) to increase
the size of the spinal canal and relieve pressure on the spinal cord and nerve
roots.
The surgeon may also make an incision in the dura (the covering of the brain) to
examine the brain and spinal cord. Additional tissue may be added to the dura to
create more space for the flow of CSF.
Infants and children with myelomeningocele may require surgery to reposition the
spinal cord and close the opening in the back.
Hydrocephalus may be treated with a shunt system that drains excess fluid and
relieves pressure inside the head. A sturdy tube that is surgically inserted
into the head is connected to a flexible tube that is placed under the skin,
where it can drain the excess fluid into either the chest wall or the abdomen so
it can be absorbed by the body.
Similarly, surgeons may open the spinal cord and insert a shunt to drain a
syringomyelia or hydromyelia. A small tube or catheter may be inserted into the
syrinx for continued drainage.
Within the Federal government, the National Institute of Neurological
Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH),
supports and conducts research on brain and nervous system disorders, including
Chiari malformations. The NINDS conducts research in its laboratories at the NIH,
in Bethesda, Maryland, and supports research through grants to major medical
institutions across the country.
In one study, NINDS scientists are trying to locate the genes responsible for
the malformation by examining CM patients who have a family member with either a
CM or syringomyelia.
Another NINDS study is reviewing an alternative surgical treatment for
syringomyelia. By examining patients with syringomyelia, in which there is an
obstruction in CSF flow, NINDS scientists hope to learn whether a surgical
procedure that relieves the obstruction in CSF flow can correct the problem
without having to cut into the spinal cord itself.
The NIH’s Management of Myelomeningocele Study is comparing prenatal surgery to
the conventional post-birth approach of closing the opening in the spine and
back that is common to some forms of CM. The study will enroll 200 women whose
fetuses have spina bifida and will compare the safety and efficacy of the
different surgeries. Preliminary clinical evidence of intrauterine closure of
the myelomeningocele suggests the procedure reduces the incidence of
shunt-dependent hydrocephalus and restores the cerebellum and brainstem to more
normal configuration. At 1 year and 2 ½ years after surgery the children will be
tested for motor function, developmental progress, and bladder, kidney, and
brain development.
For more information on neurological disorders or research programs funded by the National Institute of Neurological Disorders and Stroke, contact the Institute's Brain Resources and Information Network (BRAIN) at:
BRAIN
P.O. Box 5801
Bethesda, MD 20824
(800) 352-9424
http://www.ninds.nih.gov
Information also is available from the following organizations:
| March of Dimes Birth Defects
Foundation 1275 Mamaroneck Avenue White Plains, NY 10605 askus@marchofdimes.com http://www.marchofdimes.com Tel: 914-428-7100 888-MODIMES (663-4637) Fax: 914-428-8203 |
National Organization for Rare
Disorders (NORD) P.O. Box 1968 (55 Kenosia Avenue) Danbury, CT 06813-1968 orphan@rarediseases.org http://www.rarediseases.org Tel: 203-744-0100 Voice Mail 800-999-NORD (6673) Fax: 203-798-2291 |
| Spina Bifida Association of
America 4590 MacArthur Blvd. NW Suite 250 Washington, DC 20007-4266 sbaa@sbaa.org http://www.sbaa.org Tel: 202-944-3285 800-621-3141 Fax: 202-944-3295 |
American Syringomyelia Alliance
Project (ASAP) P.O. Box 1586 Longview, TX 75606-1586 info@asap.org http://www.asap.org Tel: 903-236-7079 800-ASAP-282 (272-7282) Fax: 903-757-7456 |
| *Disclaimer: The information available on this website should not be used as a substitute for professional medical care for the prevention, diagnosis, or treatment of your child's reflux. Please consult with your child's doctor or pharmacist before trying any medication (prescription or OTC) or following any treatment plan mentioned. This information is provided only to help you be as informed as possible about your child's condition. |
|
©2001-2007 InfantRefluxDisease.com. All Rights Reserved. No part of this website may be rewritten, reproduced, or copied in any way without prior written permission from InfantRefluxDisease.com |